Evidence map›Paper›PMID 18648508›Full record

ArticlePloS one2008

Nod2 mediates susceptibility to Yersinia pseudotuberculosis in mice.

Ulrich Meinzer, Sophie Esmiol-Welterlin, Frederick Barreau, Dominique Berrebi, Monique Dussaillant, Stephane Bonacorsi, Fabrice Chareyre, Michiko Niwa-Kawakita, Corinne Alberti, Ghislaine Sterkers and 9 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Prevalence ofFrontiers in cellular and infection microbiology · 2018
    Article
  4. Microbiota Composition and Immune Responses DuringEuropean journal of microbiology & immunology · 2017
    Article
  5. Nod2: The intestinal gate keeper.PLoS pathogens · 2017
    Review
  6. Article
  7. Gut pathogens · 2017
    Article
  8. Immune responses uponGut pathogens · 2017
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 3 countries.

Ulrich MeinzerINSERM, U843, Université Paris 7, Hôpital Robert Debré, Paris, France.
Sophie Esmiol-Welterlin
Frederick Barreau
Dominique Berrebi
Monique Dussaillant
Stephane Bonacorsi
Fabrice Chareyre
Michiko Niwa-Kawakita
Corinne Alberti
Ghislaine Sterkers
Claude Villard
Thecla Lesuffleur
Michel Peuchmaur
Michael Karin
Lars Eckmann
Marco Giovannini
Vincent Ollendorff
Hans Wolf-Watz
Jean-Pierre Hugot
Université Paris Cité · FRHôpital Robert-Debré · FRAssistance Publique – Hôpitaux de Paris · FRDélégation Paris 7 · FRInserm · FRUniversity of California, San Diego · USCentre National de la Recherche Scientifique · FRUmeå University · SEUniversité de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nucleotide oligomerisation domain 2 (NOD2) is a component of the innate immunity known to be involved in the homeostasis of Peyer patches (PPs) in mice. However, little is known about its role during gut infection in vivo. Yersinia pseudotuberculosis is an enteropathogen causing gastroenteritis, adenolymphitis and septicaemia which is able to invade its host through PPs. We investigated the role of Nod2 during Y. pseudotuberculosis infection. Death was delayed in Nod2 deleted and Crohn's disease associated Nod2 mutated mice orogastrically inoculated with Y. pseudotuberculosis. In PPs, the local immune response was characterized by a higher KC level and a more intense infiltration by neutrophils and macrophages. The apoptotic and bacterial cell counts were decreased. Finally, Nod2 deleted mice had a lower systemic bacterial dissemination and less damage of the haematopoeitic organs. This resistance phenotype was lost in case of intraperitoneal infection. We concluded that Nod2 contributes to the susceptibility to Y. pseudotuberculosis in mice.

Indexed as

Genetic Predisposition to DiseaseAnimalsApoptosisBone Marrow CellsDisease SusceptibilityGene DeletionHomeostasisMiceMice, Inbred C57BLMice, TransgenicNod2 Signaling Adaptor ProteinPeyer's PatchesPhenotypeYersinia pseudotuberculosisYersinia pseudotuberculosis InfectionsNod2 protein, mouseNod2 Signaling Adaptor Protein

Identifiers

PMID18648508
PMCPMC2447872
OpenAlexW2095392693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.